Sulfadoxine-Pyrimethamine–Based Combinations for Malaria: A Randomised Blinded Trial to Compare Efficacy, Safety and Selection of Resistance in Malawi
2008

Comparing Malaria Treatments in Children

Sample size: 455 publication 10 minutes Evidence: high

Author Information

Author(s): Bell David J., Nyirongo Suzgo K., Mukaka Mavuto, Zijlstra Ed E., Plowe Christopher V., Molyneux Malcolm E., Ward Steve A., Winstanley Peter A.

Primary Institution: Liverpool School of Tropical Medicine

Hypothesis

How do different combination therapies for malaria compare in terms of efficacy and safety?

Conclusion

The combination AQ+SP was highly effective for treating malaria, but it may also lead to resistance mutations.

Supporting Evidence

  • The day 28 adequate clinical and parasitological response rate for SP was 25%, significantly lower than the combination therapies.
  • AQ+SP had an ACPR rate of 97%, outperforming CQ+SP and ART+SP.
  • Nineteen children developed neutropenia, more frequently in the AQ+SP group.

Takeaway

This study tested different malaria treatments in young children and found that one combination worked much better than the others.

Methodology

A double-blinded randomized trial comparing SP to three combination therapies in children aged 1-5 years.

Potential Biases

Potential biases in treatment allocation and outcome assessment due to the nature of the trial.

Limitations

The study may not be generalizable to older populations or different geographical areas.

Participant Demographics

Children aged 1-5 years, with a median age of approximately 22 months.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% confidence intervals provided for treatment comparisons.

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.pone.0001578

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication